HomeNewsTechnologyAutoAutomobile sales may fall 20-25% this fiscal: Ind-Ra

Automobile sales may fall 20-25% this fiscal: Ind-Ra

The latest forecast is marginally better than the earlier forecast of 22-25 percent YoY decline in sales volume in FY2021, released in June this year, Ind-Ra said.

September 29, 2020 / 17:44 IST
Story continues below Advertisement
When looking at the overall four-wheeler segment in India, hatchbacks and SUVs have been the ones doing well. While hatchbacks are favoured for the prices, SUVs are the big car of choice for many people. Sedans, on the other hand, haven’t been enjoying as much favour. Here’s a list of the best-selling sedans in the month of September.
When looking at the overall four-wheeler segment in India, hatchbacks and SUVs have been the ones doing well. While hatchbacks are favoured for the prices, SUVs are the big car of choice for many people. Sedans, on the other hand, haven’t been enjoying as much favour. Here’s a list of the best-selling sedans in the month of September.

Rating agency Ind-Ra expects automobile sales to decline by 20-25 per cent this fiscal against its earlier forecast of 22-25 percent on account of increasing preference for personal mobility and an expected demand rebound from rural and semi-urban markets.

At the same time, the rating agency has maintained a negative outlook for the auto sector for the second half of the fiscal, owing to continued weak consumer sentiments and macroeconomic headwinds amid the disruptions caused by the pandemic, Ind-Ra said in a release.

Story continues below Advertisement

The latest forecast is marginally better than the earlier forecast of 22-25 percent YoY decline in sales volume in FY2021, released in June this year, Ind-Ra said.

Favourable regulatory changes such as GST cuts or incentive-based scrappage policy could help demand revival in the medium-term, the ratings agency said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show